Company Page

Changed Risks for NEOGEN CORP (NEOG)

May 2017

Total Other Income (Expense)

Food Safety Gross Margins:

(2013)

Rodenticides, Insecticides

Common Stock

2018

Natural Toxins, Allergens

Culture Media

Operating results could

Our business sells many products through distributors, which present risks that could negatively affect our operating results

Neogen India

13412

our ability to sell certain products or negatively affect our operating results

 & General Sanitation –

May 2018

Market prices for securities of technology companies are highly volatile

5/18

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Opinion on the Consolidated Financial Statements

We are subject to substantial governmental

Accounts

25815

Neogen Latinoamerica

 & Disinfectants –

ITEM 10

ITEM 11

 & Disposables –

May 31, 2018

Receivable Allowance

ITEM 8

ITEM 9A

ITEM 9B

Animal Care

Risks Relating to Our Business

15180

Internal Control – Integrated Framework

Animal Safety:

 & Drug

Veterinary Instruments

Changes in Internal Control over Financial Reporting

Allergens

14040

12598

17429

10543

advantages to our detriment

Basis for Opinion

Fiscal 2018 –

Our dependence on suppliers could limit

27799

Management’s Report on Internal Control over Financial Reporting

Residues –

Administrative:

12871

Neogen do Brasil (including Deoxi & Rogama)

18456

 & Drug Residues –

15004

Genomics Services –

Natural Toxins,

Opinion on Internal Control over Financial

The markets for our products are extremely competitive, and our competitors may be able to utilize existing resource

regulation

be negatively impacted by economic, political or other developments in countries in which we do business

We rely heavily on third-party package delivery services, and a

10407

Tax legislation could materially adversely affect our financial results and tax liabilities

Food Safety:

Definition and Limitations of Internal Control over

Disruption of our

Neogen Europe (including Lab M & Quat-Chem)

13596

Neogen China

 & Other –

Bacterial

agricultural marketplace, which is affected by factors beyond our control

Our business strategy

22819

Financial Reporting

18931

manufacturing and service operations could have an adverse effect on our financial condition and results of operations

Research and Development:

significant disruption in these services or significant increases in prices may disrupt our ability to ship products, increase our costs and lower our profitability

Fiscal 2017 –

Life Sciences –

infrastructure and/or a security breach of our information systems could damage our reputation and have an adverse effect on operations and results

is dependent on successfully promoting internal growth and identifying and integrating acquisitions

General and

We are dependent on the

Fiscal 2018

Sales and Marketing:

Animal Safety Gross Margins: